SEC Comment Letter for CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869) (CAPR) — Nov 13, 2009

CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)
Date: Nov. 13, 2009 · CIK: 0001133869 · Accession: 0000000000-09-064580

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-34058

Date

November 9, 2009

Author

Not clearly detected

Form

UPLOAD

Company

CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 November 9, 2009 Peter M. Strumph Chief Executive Officer Nile Therapeutics, Inc. 115 Sansome Street Suite #310 San Francisco, CA 94104 Re: Nile Therapeutics, Inc. Form 10-K and 10-K/A for the Year Ended December 31, 2008 Filed March 12, 2009 and April 23, 2009 File No. 001-34058

Dear Mr. Strumph: We have completed our review of your filings and have no further comments at this time. Sincerely, J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r

cc via facsimile : Sean Nagle, Esq Fredrikson & Byron, P.A. Fax (612) 492-7077

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                  November 9, 2009   Peter M. Strumph Chief Executive Officer Nile Therapeutics, Inc.  115 Sansome Street Suite #310 San Francisco, CA 94104
Re: Nile Therapeutics, Inc.
 Form 10-K and 10-K/A for the Year Ended December 31, 2008  Filed March 12, 2009 and April 23, 2009  File No. 001-34058

 Dear Mr. Strumph:
  We have completed our review of your filings and have no further comments at
this time.
Sincerely,
           J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r

cc via facsimile :  Sean Nagle, Esq
             Fredrikson & Byron, P.A.
      Fax (612) 492-7077

SecProbe.io